2007 Archive
June 13, 2007 Delcath Fulfills Nasdaq Independent Director and Audit Committee Requirements With Addition of Two New Directors
June 5, 2007 Delcath Updates Clinical Trials
June 5, 2007 Jonathan J. Lewis, MD Joins Delcath's Board of Directors
May 30, 2007
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Center
May 24, 2007
Delcath Systems Names Laura A. Philips to Board of Directors
Delcath Systems Adds Two Executives
May 17, 2007
Delcath Systems Announces Presentation of Data at World Conference on Interventional Oncology
May 16, 2007 Delcath Systems Issues CEO Letter to Shareholders
May 10, 2007 DELCATH SYSTEMS FILES FIRST QUARTER 2007 10-Q AND SHELF REGISTRATION
April 17, 2007
Delcath Systems Announces Board Resignations
April 10, 2007 DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN
March 29, 2007 Delcath Systems Extends Cooperative Research And Development Agreement With The National Cancer Institute
February 26, 2007
Delcath Systems Reports Positive Data From Ongoing Phase II Multi-Histology Trial at the Second International Symposium on Regional Cancer Therapies
February 20, 2007 Delcath Systems to Host Conference Call & Webcast For Investors
February 15, 2007 Delcath Systems Co-Sponsors Second International Symposium On Regional Cancer Therapies
February 9, 2007 Delcath Systems Retains Former Director of Operations as Advisor
February 2, 2007 Delcath Elects Dr. Harold Koplewicz Chairman of the Board of Directors Delcath Settles Litigation Against Former Director of Operations
January 26, 2007 Delcath Announces the Resignation of M. S. Koly as Chairman of the Board of Directors
January 4, 2007 Delcath Appoints Dr. Samuel Herschkowitz as Interim COO
April 17, 2007 Delcath Systems Announces Board Resignations
Delcath stock tracker
Most recent trade:$1.22
Today's Change:0.00
(Prices delayed up to 20 minutes.)